Schedule 13G ownership disclosure

Viking Therapeutics Inc

Security class unavailable · CUSIP: 92686J106

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
15.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001564590-16-012763
Form type
SC 13G
Filer
Lian Brian
CIK
CIK 1614578
Filed
Feb 16, 2016
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub

SC 13G | SEC Filings Hub